What are the major opportunities in the Radiopharmaceuticals market? What are the strategies for the Radiopharmaceuticals market?

For detailed insights on the major opportunities and strategies in the Radiopharmaceuticals market, Read More

How does the Radiopharmaceuticals market relate to the overall economy and other similar markets?

For detailed insights on Radiopharmaceuticals's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Radiopharmaceuticals market growth? SWOT analysis of the Radiopharmaceuticals market.

For detailed insights on the key dynamics influencing the Radiopharmaceuticals market growth and SWOT analysis of the Radiopharmaceuticals industry, Read More

Radiopharmaceuticals Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Radiopharmaceuticals Market Report 2026

Name: Radiopharmaceuticals Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Diagnostic, Therapeutic), By Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Musculoskeletal, Respiratory, Nephrology, Other Applications), By End User (Hospitals And Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Radiopharmaceuticals Market Overview

• Radiopharmaceuticals market size has reached to $7.3 billion in 2025

• Expected to grow to $13.68 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%

• Growth Driver: Increasing Cancer And Cardiovascular Disease Prevalence Fuels Demand For Radiopharmaceuticals

• Market Trend: Strategic Partnerships Drive Radiopharmaceutical Innovation And Accessibility

• North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Radiopharmaceuticals Market?

Radiopharmaceuticals refer to a medication used to treat or diagnose diseases, including cancer, that contains a radioactive material. Likewise known as radioactive medication. These are the procedures used to identify certain illnesses or detect medical issues. The patient may receive them in a number of different ways. They could be injected, injected orally, or injected into the eye or bladder, for instance.

The main types of radiopharmaceuticals are diagnostic, therapeutic, and others. The delivery of radioactive atoms to tumor-associated targets is referred to as radiopharmaceutical therapeutic. The various applications include oncology, cardiology, gastroenterology, neuroendocrinology, neurology, nephrology, and others that are used by hospitals, ambulatory surgical centers, diagnostic centers, cancer research institutes, and others.

Radiopharmaceuticals Market Global Report 2026 Market Report bar graph

What Is The Radiopharmaceuticals Market Size and Share 2026?

The radiopharmaceuticals market size has grown rapidly in recent years. It will grow from $7.3 billion in 2025 to $8.25 billion in 2026 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to adoption of nuclear imaging technologies, growth in cancer diagnosis rates, availability of radioisotopes, hospital-based nuclear medicine expansion, regulatory approvals for diagnostic agents.

What Is The Radiopharmaceuticals Market Growth Forecast?

The radiopharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $13.68 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to growth in precision oncology, rising demand for targeted radiotherapies, expansion of diagnostic imaging centers, investments in cyclotron infrastructure, technological advancements in isotope production. Major trends in the forecast period include rising use of radiopharmaceuticals in oncology, growth of theranostics applications, expansion of pet and spect imaging, increasing development of targeted radiotherapies, improved nuclear medicine infrastructure.

Book your 30 minutes free consultation with our research experts

Global Radiopharmaceuticals Market Segmentation

1) By Type: Diagnostic, Therapeutic

2) By Application: Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Musculoskeletal, Respiratory, Nephrology, Other Applications

3) By End User: Hospitals And Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes

Subsegments:

1) By Diagnostic: Positron Emission Tomography (PET) Radiopharmaceuticals, Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals

2) By Therapeutic: Alpha Emitters, Beta Emitters, Brachytherapy

What Is The Driver Of The Radiopharmaceuticals Market?

The increasing prevalence of cancer and cardiovascular diseases is projected to drive the demand for the radiopharmaceuticals market. Radiopharmaceuticals are emerging as a safe and effective therapeutic option over conventional medicines. Radiopharmaceuticals provide an upper hand to radiologists to treat cancer and cardiovascular diseases due to their benefits such as targeted therapy. Cancer is considered to be the second major cause of death, with around 1 in 6 deaths due to cancer worldwide. For instance, in April 2024, according to the International Agency for Research on Cancer (IARC), a France-based specialized agency, in 2022, nearly 20 million new cancer cases and 9.7 million cancer-related deaths occurred globally. By 2040, these numbers are projected to increase to 29.9 million new cases and 15.3 million deaths annually. Thus, the rising cases of cancer and cardiovascular diseases are expected to surge the demand for radiopharmaceuticals for the treatment of these diseases.

Key Players In The Global Radiopharmaceuticals Market

Major companies operating in the radiopharmaceuticals market are Cardinal Health, Curium Pharma, Siemens Healthineers AG, Novartis AG, General Electric Company (GE), IBA Group, Bayer AG, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Eckert & Ziegler, Nihon Medi-Physics Co. Ltd., Fujifilm Corporation, ANSTO, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Bracco Imaging SpA., Canon Inc., China Isotope & Radiation Corporation (CIRC), Alliance Medical, Advanced Accelerator Applications, JSC Isotope, Pharm-Sintez, Synektik SA, Polatom, RadioMedic sro, ÚJV Rež, Actinium Pharmaceuticals Inc., Alseres Pharmaceuticals Inc., Avid Radiopharmaceuticals, Fusion Pharmaceuticals, Peregrine Pharmaceuticals Inc., PETNET Solutions Inc., Positron Corporation, Triad Isotopes Inc., Telix Pharmaceuticals, Rosatom, Alliance Medical Group, Hologic Inc., Segami Corporation, Eczacýbaþý-Monrol Nuclear Products, NTP Radioisotopes.

Global Radiopharmaceuticals Market Trends and Insights

Major companies operating in the radiopharmaceuticals market are increasingly forming strategic partnerships to accelerate innovation and expand access to advanced diagnostic and therapeutic solutions. These collaborations focus on enhancing radiopharmaceutical development, strengthening regional production capabilities, and supporting the growing demand for precision imaging and targeted therapies. For instance, in June 2023, the University of Pittsburgh Medical Center (UPMC), a US-based hospital system, partnered with PharmaLogic Holdings Corporation to co-develop and manufacture new radiopharmaceuticals at a Pittsburgh facility. The partnership aims to expand patient and clinician access to cutting-edge diagnostic and therapeutic agents that are not currently available in nearby regions. Under the non-exclusive agreement, UPMC and PharmaLogic will translate experimental radiopharmaceuticals into clinically useful medications, supporting broader commercialization and accelerating the adoption of novel nuclear medicine treatments.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Radiopharmaceuticals Market?

In January 2024, Eli Lilly, a US-based pharmaceutical company, completed its acquisition of Point Biopharma for approximately $1.4 billion. This acquisition supports Lilly's strategy to enhance its capabilities in the emerging field of radioligand therapies, which aim to provide significant advancements in cancer treatment. Point Biopharma specializes in radiopharmaceuticals, aligning well with Lilly's existing oncology portfolio and promising to improve patient outcomes. Point Biopharma is a US-based company focused on developing targeted radioligand therapies for various cancers.

Regional Insights

North America was the largest region in the global radiopharmaceuticals market in 2025. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Radiopharmaceuticals Market?

The radiopharmaceuticals market consists of sales of technetium disofenin, technetium lidofenin, and technetium mebrofenin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Radiopharmaceuticals Market Report 2026?

The radiopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the radiopharmaceuticals industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Radiopharmaceuticals Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$8.25 billion
Revenue Forecast In 2035	$13.68 billion
Growth Rate	CAGR of 13.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Cardinal Health, Curium Pharma, Siemens Healthineers AG, Novartis AG, General Electric Company (GE), IBA Group, Bayer AG, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Eckert & Ziegler, Nihon Medi-Physics Co. Ltd., Fujifilm Corporation, ANSTO, Ya
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Radiopharmaceuticals Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Radiopharmaceuticals Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Radiopharmaceuticals Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Radiopharmaceuticals Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Use Of Radiopharmaceuticals In Oncology

4.2.2 Growth Of Theranostics Applications

4.2.3 Expansion Of PET And SPECT Imaging

4.2.4 Increasing Development Of Targeted Radiotherapies

4.2.5 Improved Nuclear Medicine Infrastructure

5. Radiopharmaceuticals Market Analysis Of End Use Industries

5.1 Hospitals And Ambulatory Surgical Centers

5.2 Diagnostic Imaging Centers

5.3 Cancer Treatment Centers

5.4 Nuclear Medicine Clinics

5.5 Research Institutes

6. Radiopharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Radiopharmaceuticals Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Radiopharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Radiopharmaceuticals Market Size, Comparisons And Growth Rate Analysis

7.3. Global Radiopharmaceuticals Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Radiopharmaceuticals Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Radiopharmaceuticals Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Radiopharmaceuticals Market Segmentation

9.1. Global Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostic, Therapeutic

9.2. Global Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Musculoskeletal, Respiratory, Nephrology, Other Applications

9.3. Global Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes

9.4. Global Radiopharmaceuticals Market, Sub-Segmentation Of Diagnostic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Positron Emission Tomography (PET) Radiopharmaceuticals, Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals

9.5. Global Radiopharmaceuticals Market, Sub-Segmentation Of Therapeutic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Alpha Emitters, Beta Emitters, Brachytherapy

10. Radiopharmaceuticals Market Regional And Country Analysis

10.1. Global Radiopharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Radiopharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Radiopharmaceuticals Market

11.1. Asia-Pacific Radiopharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Radiopharmaceuticals Market

12.1. China Radiopharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Radiopharmaceuticals Market

13.1. India Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Radiopharmaceuticals Market

14.1. Japan Radiopharmaceuticals Market Overview

14.2. Japan Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Radiopharmaceuticals Market

15.1. Australia Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Radiopharmaceuticals Market

16.1. Indonesia Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Radiopharmaceuticals Market

17.1. South Korea Radiopharmaceuticals Market Overview

17.2. South Korea Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Radiopharmaceuticals Market

18.1. Taiwan Radiopharmaceuticals Market Overview

18.2. Taiwan Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Radiopharmaceuticals Market

19.1. South East Asia Radiopharmaceuticals Market Overview

19.2. South East Asia Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Radiopharmaceuticals Market

20.1. Western Europe Radiopharmaceuticals Market Overview

20.2. Western Europe Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Radiopharmaceuticals Market

21.1. UK Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Radiopharmaceuticals Market

22.1. Germany Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Radiopharmaceuticals Market

23.1. France Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Radiopharmaceuticals Market

24.1. Italy Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Radiopharmaceuticals Market

25.1. Spain Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Radiopharmaceuticals Market

26.1. Eastern Europe Radiopharmaceuticals Market Overview

26.2. Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Radiopharmaceuticals Market

27.1. Russia Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Radiopharmaceuticals Market

28.1. North America Radiopharmaceuticals Market Overview

28.2. North America Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Radiopharmaceuticals Market

29.1. USA Radiopharmaceuticals Market Overview

29.2. USA Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Radiopharmaceuticals Market

30.1. Canada Radiopharmaceuticals Market Overview

30.2. Canada Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Radiopharmaceuticals Market

31.1. South America Radiopharmaceuticals Market Overview

31.2. South America Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Radiopharmaceuticals Market

32.1. Brazil Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Radiopharmaceuticals Market

33.1. Middle East Radiopharmaceuticals Market Overview

33.2. Middle East Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Radiopharmaceuticals Market

34.1. Africa Radiopharmaceuticals Market Overview

34.2. Africa Radiopharmaceuticals Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Radiopharmaceuticals Market Regulatory and Investment Landscape

36. Radiopharmaceuticals Market Competitive Landscape And Company Profiles

36.1. Radiopharmaceuticals Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Radiopharmaceuticals Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Radiopharmaceuticals Market Company Profiles

36.3.1. Cardinal Health Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. General Electric Company (GE) Overview, Products and Services, Strategy and Financial Analysis

37. Radiopharmaceuticals Market Other Major And Innovative Companies

IBA Group, Bayer AG, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Eckert & Ziegler, Nihon Medi-Physics Co. Ltd., Fujifilm Corporation, ANSTO, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Bracco Imaging SpA., Canon Inc., China Isotope & Radiation Corporation (CIRC), Alliance Medical, Advanced Accelerator Applications, JSC Isotope

38. Global Radiopharmaceuticals Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Radiopharmaceuticals Market

40. Radiopharmaceuticals Market High Potential Countries, Segments and Strategies

40.1 Radiopharmaceuticals Market In 2030 - Countries Offering Most New Opportunities

40.2 Radiopharmaceuticals Market In 2030 - Segments Offering Most New Opportunities

40.3 Radiopharmaceuticals Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Radiopharmaceuticals Market, Overview Of Key Products - Product Examples

Table 2: Global Radiopharmaceuticals Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Radiopharmaceuticals Market, Supply Chain Analysis

Table 4: Global Radiopharmaceuticals Market, Major Raw Material Providers

Table 5: Global Radiopharmaceuticals Market, Major Resource Providers

Table 6: Global Radiopharmaceuticals Market, Major Manufacturers (Suppliers)

Table 7: Global Radiopharmaceuticals Market, Major Distributors And Channel Partners

Table 8: Global Radiopharmaceuticals Market, Key Technologies & Future Trends

Table 9: Global Radiopharmaceuticals Market, Major Trends

Table 10: Global Radiopharmaceuticals Market, Major End Users

Table 11: Global Radiopharmaceuticals Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Radiopharmaceuticals Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Radiopharmaceuticals Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Radiopharmaceuticals Market - TAM, US$ Billion, 2025

Table 15: Global Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Radiopharmaceuticals Market, Sub-Segmentation Of Diagnostic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Radiopharmaceuticals Market, Sub-Segmentation Of Therapeutic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Radiopharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Radiopharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global Radiopharmaceuticals Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global Radiopharmaceuticals Market - Company Scoring Matrix

Table 96: Cardinal Health Financial Performance

Table 97: Curium Pharma Financial Performance

Table 98: Siemens Healthineers AG Financial Performance

Table 99: Novartis AG Financial Performance

Table 100: General Electric Company (GE) Financial Performance

Table 101: Global Radiopharmaceuticals Market, Competitive Benchmarking (In USD Billions)

Table 102: Global Radiopharmaceuticals Market, Competitive Dashboard

Table 103: Global Radiopharmaceuticals Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 104: Global, Radiopharmaceuticals Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 105: Global, Radiopharmaceuticals Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 106: Global, Radiopharmaceuticals Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global Radiopharmaceuticals Market, Overview Of Key Products - Product Examples

Figure 2: Global Radiopharmaceuticals Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Radiopharmaceuticals Market, Supply Chain Analysis

Figure 4: Global Radiopharmaceuticals Market, Major Raw Material Providers

Figure 5: Global Radiopharmaceuticals Market, Major Resource Providers

Figure 6: Global Radiopharmaceuticals Market, Major Manufacturers (Suppliers)

Figure 7: Global Radiopharmaceuticals Market, Major Distributors And Channel Partners

Figure 8: Global Radiopharmaceuticals Market, Key Technologies & Future Trends

Figure 9: Global Radiopharmaceuticals Market, Major Trends

Figure 10: Global Radiopharmaceuticals Market, Major End Users

Figure 11: Global Radiopharmaceuticals Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Radiopharmaceuticals Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Radiopharmaceuticals Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Radiopharmaceuticals Market - TAM, US$ Billion, 2025

Figure 15: Global Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Radiopharmaceuticals Market, Sub-Segmentation Of Diagnostic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Radiopharmaceuticals Market, Sub-Segmentation Of Therapeutic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Radiopharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Radiopharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global Radiopharmaceuticals Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global Radiopharmaceuticals Market - Company Scoring Matrix

Figure 96: Cardinal Health Financial Performance

Figure 97: Curium Pharma Financial Performance

Figure 98: Siemens Healthineers AG Financial Performance

Figure 99: Novartis AG Financial Performance

Figure 100: General Electric Company (GE) Financial Performance

Figure 101: Global Radiopharmaceuticals Market, Competitive Benchmarking (In USD Billions)

Figure 102: Global Radiopharmaceuticals Market, Competitive Dashboard

Figure 103: Global Radiopharmaceuticals Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 104: Global, Radiopharmaceuticals Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 105: Global, Radiopharmaceuticals Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 106: Global, Radiopharmaceuticals Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Diagnostic Imaging Equipment Market Report 2026 - Global Outlook – By Imaging Modality (X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipme...

Oncology Molecular Diagnostics Market Report 2026 - Global Outlook – By Product (Instruments, Reagents, Other Products), By Technology (Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Isothermic Nucleic Aci...

Point-of-Care Diagnostics Devices And Equipment Market Report 2026 - Global Outlook – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests ki...

Medical And Diagnostic Laboratory Services Market Report 2026 - Global Outlook – By Type (Diagnostic Imaging Centers, Medical Laboratory Services), By Type of Expenditure (Public, Private), By Application (Cardiology, On...

Medical Equipment Market Report 2026 - Global Outlook – By Type (In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical ...

Radiotherapy Devices Market Report 2026 - Global Outlook – By Product Type (External Beam Radiation Therapy Devices, Linear Accelerator Devices, Proton Therapy Devices), By Application (Skin Cancer, Breast Cancer, Prosta...

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Frequently Asked Questions

What is the projected market size of the Radiopharmaceuticals Market Report 2026 market by 2030?

The Radiopharmaceuticals Market Report 2026 market was valued at $7.3 billion in 2025, increased to $8.25 billion in 2026, and is projected to reach $13.68 billion by 2030. request a sample here

What is the expected CAGR for the Radiopharmaceuticals Market Report 2026 market during the forecast period 2025 - 2030?

The expected CAGR for the Radiopharmaceuticals Market Report 2026 market during the forecast period 2025–2030 is 13.5%. request a sample here

What are the key factors driving the Radiopharmaceuticals Market Report 2026 market?

Major growth driver of the market includes: Increasing Cancer And Cardiovascular Disease Prevalence Fuels Demand For Radiopharmaceuticals in the Radiopharmaceuticals Market Report 2026 market. For further insights on this market, request a sample here

Which end-use segment are covered in the Radiopharmaceuticals Market Report 2026 market report?

The radiopharmaceuticals market covered in this report is segmented –
1) By Type: Diagnostic, Therapeutic
2) By Application: Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Musculoskeletal, Respiratory, Nephrology, Other Applications
3) By End User: Hospitals And Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes Subsegments:
1) By Diagnostic: Positron Emission Tomography (PET) Radiopharmaceuticals, Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
2) By Therapeutic: Alpha Emitters, Beta Emitters, Brachytherapy request a sample here

What is the anticipated growth trend for the Radiopharmaceuticals Market Report 2026 market?

Major trend in this market includes: Strategic Partnerships Drive Radiopharmaceutical Innovation And Accessibility For further insights on this market, request a sample here.

Who are the key players in the Radiopharmaceuticals Market Report 2026 market?

Major companies operating in the Radiopharmaceuticals Market Report 2026 market are Major companies operating in the radiopharmaceuticals market are Cardinal Health, Curium Pharma, Siemens Healthineers AG, Novartis AG, General Electric Company (GE), IB request a sample here.

North America was the largest region in the global radiopharmaceuticals market in 2025. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the radiopharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Book your 30 minutes free consultation with our research experts

Contact Us